Informações:
Falhas:
ID
34410
Descrição
Dalfampridine for Imbalance in Multiple Sclerosis; ODM derived from: https://clinicaltrials.gov/show/NCT01444300
Link
https://clinicaltrials.gov/show/NCT01444300
Palavras-chave
Versões (1)
- 17/01/2019 17/01/2019 -
Titular dos direitos
see on clinicaltrials.gov
Transferido a
17 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Multiple Sclerosis NCT01444300
Eligibility Multiple Sclerosis NCT01444300
- StudyEvent: Eligibility
Similar models
Eligibility Multiple Sclerosis NCT01444300
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
ID.1
Item
age 20- 59 years,
boolean
ID.2
Item
able to walk at least 100m without an aide or with unilateral assistance
boolean
ID.3
Item
prolonged apr latencies (≥ 1sd > mean for healthy people in this age range) or,
boolean
ID.4
Item
reduced balance-related activity (abc scores ≤ 85%),
boolean
ID.5
Item
abnormal trunk range of motion (horizontal), trunk range of motion (frontal), turning duration, cadence, double support time, stride length or gait cycle time (outside 1sd of the average for healthy people in this age range)
boolean
ID.6
Item
currently taking dalfampridine (any within the last 2 weeks),
boolean
ID.7
Item
cause(s) of imbalance other than ms,
boolean
ID.8
Item
impaired renal function (creatinine clearance ≤50ml/min),
boolean
ID.9
Item
seizure disorder
boolean
ID.10
Item
pregnancy or breast feeding
boolean